- In January 2025, BD announced the commercial availability of its next-generation 4mm ultra-thin pen needle in the U.S., focusing on pain-free insulin delivery.
- In February 2025, Novo Nordisk expanded its diabetes care outreach program in Canada, distributing pen needle starter kits to newly diagnosed patients.
- In March 2025, Embecta launched an e-commerce portal offering direct-to-consumer sales of pen needles across North America.
- In April 2025, Terumo Corporation partnered with U.S. health systems to pilot a safety pen needle design aimed at reducing needlestick injuries among home users.
